NCT03522831View on ClinicalTrials.gov

CF Bronchodilation

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Lung DiseasesCystic Fibrosis
Interventions
DRUG

Salbutamol

Administration of 400 μg meter-dose inhaler of salbutamol performed using large-volume spacer

DRUG

Placebo

Administration of 400 μg meter-dose inhaler of placebo performed using large-volume spacer

Trial Locations (1)

V6Z1Y6

UBC Cardiopulmonary Exercise Physiology Laboratory, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER